Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Acute Effects of Upper Arm Tissue Flossing on Upper Extremity Performance and Power (AUERTF)

22. juni 2026 opdateret af: esedullah akaras, Erzurum Technical University

Acute Effects of Upper Arm Tissue Flossing on Closed-Chain Upper Extremity Stability and Explosive Upper-Body Power: A Randomized Sham-Controlled Trial

This randomized sham-controlled trial investigates the acute effects of upper arm tissue flossing on upper extremity performance and power in healthy adults. Tissue flossing is a compression-based intervention that involves wrapping an elastic band around a limb for a short period while performing movement exercises.

Twenty-eight healthy participants are randomly assigned to either an active tissue flossing group or a sham flossing group. The intervention is applied to the dominant upper arm. Upper extremity performance is assessed before the intervention and at 2 and 15 minutes after the intervention using the Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) and the Seated Medicine Ball Throw (SMBT).

The study aims to determine whether a single session of upper arm tissue flossing can produce immediate improvements in upper extremity stability, functional performance, and explosive power compared with a sham intervention

Studieoversigt

Detaljeret beskrivelse

Tissue flossing is a relatively new technique used in sports and rehabilitation settings. It involves applying a specialized elastic compression band around a limb while the individual performs active movements. Proposed mechanisms include temporary vascular occlusion followed by reperfusion, alterations in neuromuscular function, and changes in fascial tissue mobility. Although tissue flossing has been investigated for lower extremity performance and range of motion outcomes, evidence regarding its effects on upper extremity performance remains limited.

The purpose of this study is to examine the acute effects of upper arm tissue flossing on upper extremity functional performance and power in healthy adults. This study is designed as a randomized, sham-controlled, parallel-group trial.

A total of 28 healthy volunteers are randomly allocated to either an active tissue flossing group or a sham flossing group. Participants in the active intervention group receive tissue flossing applied to the dominant upper arm using a standardized compression protocol. Participants in the sham group receive a loosely applied band that does not provide therapeutic compression. During band application, participants perform standardized upper extremity movements.

Outcome measurements are obtained at baseline, 2 minutes after intervention, and 15 minutes after intervention. Upper extremity functional performance is assessed using the Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST). Explosive upper-body power is assessed using the Seated Medicine Ball Throw (SMBT).

The primary objective is to determine whether upper arm tissue flossing produces immediate improvements in upper extremity stability and performance compared with a sham intervention. Findings from this study may contribute to understanding the potential role of tissue flossing as a practical strategy for enhancing upper extremity performance in healthy individuals and physically active populations.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

28

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ja

Beskrivelse

Inclusion Criteria:

  1. Age 18-35 years.
  2. Absence of current upper-extremity pain or dysfunction.
  3. Ability to safely assume a full push-up position and perform a two-handed seated chest pass.

Exclusion Criteria:

  1. History of upper-extremity surgery.
  2. Acute musculoskeletal injury within the preceding 6 months.
  3. Known vascular disease, coagulation or clotting disorders, uncontrolled hypertension, or any other contraindication to short-term circumferential limb compression.
  4. Confirmed latex allergy, given that the floss band used in this study was latex-based.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Active Flossing Group
Participants (n=14) receive a structured circumferential compression protocol on their dominant upper arm using an elastic latex floss band stretched to moderate tension, followed by a brief active movement sequence.
The floss band is applied to the participant's dominant upper arm by a licensed physiotherapist. Wrapping proceeds in a distal-to-proximal direction with approximately 50% overlap between layers, terminating just distal to the axilla. The band is stretched to a standardized elongation between 50% and 70% of its maximal length to generate moderate circumferential compression. Once wrapped, the participant performs a standardized 2-minute low-to-moderate intensity active movement sequence consisting of repeated elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination. The band is fully removed immediately following the 2-minute movement block
The floss band is applied to the participant's dominant upper arm by the same physiotherapist, maintaining identical therapist contact time, limb positioning, and overall session duration as the active group. However, the band is applied with less than 10% elongation, creating a loosely snug contact fit insufficient to generate meaningful circumferential compression or local vascular occlusion. Once wrapped, the participant performs the exact same 2-minute low-to-moderate intensity active movement sequence (elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination) before the band is fully removed.
Sham-komparator: Sham Flossing
Participants (n=14) receive a loose, minimal-tension wrap on their dominant upper arm using the same floss band type, performing the identical active movement sequence to isolate the effects of compression intensity
The floss band is applied to the participant's dominant upper arm by a licensed physiotherapist. Wrapping proceeds in a distal-to-proximal direction with approximately 50% overlap between layers, terminating just distal to the axilla. The band is stretched to a standardized elongation between 50% and 70% of its maximal length to generate moderate circumferential compression. Once wrapped, the participant performs a standardized 2-minute low-to-moderate intensity active movement sequence consisting of repeated elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination. The band is fully removed immediately following the 2-minute movement block
The floss band is applied to the participant's dominant upper arm by the same physiotherapist, maintaining identical therapist contact time, limb positioning, and overall session duration as the active group. However, the band is applied with less than 10% elongation, creating a loosely snug contact fit insufficient to generate meaningful circumferential compression or local vascular occlusion. Once wrapped, the participant performs the exact same 2-minute low-to-moderate intensity active movement sequence (elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination) before the band is fully removed.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Seated Medicine Ball Throw (SMBT) distance
Tidsramme: Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal
Upper-extremity explosive power was assessed using the seated medicine ball throw. Participants were seated upright with back support and projected a 2-kg medicine ball horizontally as far as possible in a chest-pass motion. Throw distance was measured from a fixed start line to the point of initial ball contact.
Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal
Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) score
Tidsramme: Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal.
Upper-extremity closed-chain stability was assessed using the CKCUEST. Participants assumed a full push-up (high-plank) position with hands placed on two parallel strips of tape positioned 91.4 cm apart. Participants alternately touched the opposite hand as rapidly as possible for 15 seconds. The metric recorded is the total number of completed hand touches within the 15-second interval.
Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studiestol: Esedullah AKARAS, Dr., Erzurum Technical University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. marts 2026

Primær færdiggørelse (Faktiske)

15. april 2026

Studieafslutning (Faktiske)

3. maj 2026

Datoer for studieregistrering

Først indsendt

22. juni 2026

Først indsendt, der opfyldte QC-kriterier

22. juni 2026

Først opslået (Faktiske)

26. juni 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

26. juni 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

22. juni 2026

Sidst verificeret

1. februar 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • ETU-2026-TF-UEP-01

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

our protocol explicitly states that the datasets generated and analyzed during the study are openly available.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner